The global health community has made significant strides in the fight against hepatitis, yet the journey towards its elimination remains fraught with challenges, particularly in regions such as Africa, writes Bada Pharasi, CEO at the Innovative Pharmaceutical Association of South Africa, and Professor Wendy Spearman,...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Internationally, 17 September, is recognised as World Patient Safety Day (WPSD), one of the World Health Organisation’s (WHO’s) global public health days. The 2023 theme, is       “Elevate the voice of patients!”, prioritises the need for patient centred healthcare,...

With Rwanda’s Universal Health Coverage (UHC) initiative ensuring adequate healthcare for almost 90% of its population, there are several learnings that South Africa can implement to ensure the long-term success of its planned National Health Insurance (NHI) initiative, writes Bada Pharasi, CEO of the Innovative...

The Innovative Pharmaceutical Association of South Africa (IPASA) congratulates the South African Health Products Regulatory Authority (SAHPRA) on achieving a functional level of maturity (Level 3) for its vaccine regulation, according to the World Health Organization’s (WHO’s) global classification system for national medical products regulatory...

Early detection coupled with innovative technologies and medications are crucial to reducing breast cancer mortality rates in South Africa, writes Dr Mothobi Godfrey Keele, Head of Government Affairs and Policy, Innovative Pharmaceutical Association of South Africa (IPASA).   Given that South Africa recently observed Breast Cancer Awareness...